Markets:

Overview

News

Currencies

International

Treasuries

NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

3.235 +0.175 (+5.72%)

Streaming Delayed Price Updated: 11:53 AM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NRX Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 03, 2022

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 08, 2022

During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...

Via Benzinga

18 Stocks Moving in Wednesday's Pre-Market Session ↗

June 01, 2022

Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher ↗

May 26, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 575 points on Thursday.

Via Benzinga

Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today? ↗

May 26, 2022

Today, investors in NRx Pharmaceuticals and NRXP stock have seen heavy selling pressure as a key trial was stopped due to futility.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 26, 2022

Via Benzinga

Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble ↗

May 26, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 1.5% on Thursday.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

May 26, 2022

On Thursday, 94 companies set new 52-week lows.

Via Benzinga

61 Stocks Moving In Thursday's Mid-Day Session ↗

May 26, 2022

Via Benzinga

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review ↗

May 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday? ↗

May 26, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 26, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

20 Stocks Moving in Thursday's Pre-Market Session ↗

May 26, 2022

Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 51.2% to $0.9603 in pre-market trading after dipping 18% on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 20, 2022

Via Benzinga

NASDAQ:NRXP Long Term Investor Alert: Investigation over Possible Wrongdoing at NRx Pharmaceuticals, Inc. ↗

May 16, 2022

San Diego, CA -- (SBWIRE) -- 05/16/2022 -- Certain directors of NRx Pharmaceuticals, Inc. are under investigation over possible breaches of fiduciary duties.

Via SBWire

NRX PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP

May 05, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

NRX PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP

April 29, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy ↗

April 21, 2022

Via Benzinga

NRX PHARMACEUTICALS INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP

April 09, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

53 Biggest Movers From Yesterday ↗

April 01, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 31, 2022

Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

March 31, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with...

Via Benzinga

NRx Pharma Says I-SPY Study Of Inhaled Zyesami In Critical COVID-19 Stopped ↗

March 31, 2022

Quantum Leap Healthcare Collaborative (QLHC) announced that the nebulized form of NRx Pharmaceuticals Inc's (NASDAQ: NRXP) Zyesami (Aviptadil) in the I-SPY COVID Trial of

Via Benzinga

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

NRX Pharmaceuticals Q4 2021 Earnings Conference Call On March 31, 2022 At 08:30 AM ET ↗

March 29, 2022

NRX Pharmaceuticals (NASDAQ:NRXP) will host a conference call at 08:30 AM ET on March 31, 2022, to discuss Q4 2021 earnings results.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.